Evolution of Canadian Intellectual Property Legislation Affecting Innovative Drug Products

January 2012

Contacts

Key industry sectors

The Norton Rose Canada LLP Guide to the "Evolution of Canadian Intellectual Property Legislation Affecting Innovative Drug Products" provides a brief historical survey of the legislative protection extended to innovative drug products in Canada, including a consideration of Canada's international treaty obligations respecting IP rights.

Download Evolution of Canadian Intellectual Property Legislation Affecting Innovative Drug Products (pdf 431kb)